Pashtoon Kasi MD, MS· @pashtoonkasi · X·· 2026-04-21Score60
Body
#AACR26 Come to our session tomorrow.
We call it the CLOVERTrial.
CCR5-targeting
Leronlimab with
Oral chemotherapy &
VEGF-inhibitor
Enriched
Regimen
2-5 PM
Building upon options for our patients with #ColorectalCancer.
@OncoAlert
@cityofhope
Heat 36 · 26 likes · 2 replies · 8 reposts
Conference abstracts
1033matched by 药名 leronlimab
Leronlimab induces PD-L1 expression and is associated with long-term survival with an ICI in PD-L1 low metastatic TNBCRichard G. Pestell, Ritika Harish, Zhiping Li, Danni Li, Xuanmao Jiao, Hallgeir Rui, Massimo Cristofanilli, Daniel L. Adams, Neil E. Buss, Jonah B. Sacha, Jacob P. Lalezari
Read the abstract →6466matched by 药名 leronlimab
Preliminary results of a phase 2 study of leronlimab in combination with TAS-102 and bevacizumab in previously treated metastatic colorectal cancerPashtoon M. Kasi, Ari Baron, Arvind Chaudhry, Laura Tenner, Daniel L. Adams, Alexis B. Duffy, Hallgeir Rui, Patrick Vittner, Joseph Meidling, Jacob P. Lalezari
Read the abstract →Source: Pashtoon Kasi MD, MS · x.com